InTERNATIONAL KEYNOTE SPEAKERS
We are gathering a fantastic lineup of speakers and are excited to provide a platform for them to share their expertise, provide key insights and advice, and inspire. Details of invited speakers will be added as arrangements are confirmed.
Dr. Fabien Hyafil, MD, PhD, FESC
Senior Consultant, Department of Nuclear Medicine, Bichat Hospital, ParisProf. Pek-Lan Khong
Clinical Professor of Radiology, Head Department of Diagnostic Radiology, The University of Hong KongProf. Pek-Lan Khong is Clinical Professor of Radiology and the Head of Department of Diagnostic Radiology, The University of Hong Kong since 2008. She serves as Honorary Consultant Radiologist at Queen Mary Hospital, Hong Kong, and Hong Kong Children’s Hospital. She was also Chief-of-Service of the Department of Medical Imaging, The University of Hong Kong- Shenzhen Hospital, PRC, between 2012-2017 from the founding of the hospital.
Prof. Khong received her medical degree from The National University of Singapore, and subsequently trained in Radiology obtaining her specialist degrees in Hong Kong (FHKCR, FHKAM) and the United Kingdom (FRCR), and her post-graduate Doctor of Medicine degree (MD) from The University of Hong Kong.
Prof. Khong’s research focus is in pediatric neuroradiology, in particular, the pediatric applications of diffusion-weighted and diffusion-tensor MR imaging, and in oncological imaging, with a focus on hybrid-PET imaging. She established the clinical and research molecular imaging facilities in the Department, which includes a cyclotron and radiopharmacy lab and pre-clinical translational research lab. Published works include more than 200 original articles in international peer-review journals on topics of pediatric neuroradiology, hybrid-PET imaging in oncology, and radiological protection in Medicine. She sits on the review board of multiple national grant funding bodies and lectures regionally and internationally.
Prof. Khong is a Fellow of the International Society of Magnetic Resonance in Medicine (ISMRM) and Fellow of the International Cancer Imaging Society (ICIS). She is currently a member of the Board of Trustees of the ISMRM, an Executive Board member of the International Society of Strategic Studies in Radiology (IS3R), and a member of the RSNA Regional Committee for China. From 2009-2017, Dr. Khong was elected to the International Commission on Radiological Protection (ICRP), committee on Protection in Medicine, and the co-corresponding author of ICRP Publication 121 on “Radiological Protection in Pediatric Diagnostic and Interventional Radiology”.
Prof. Fabian Kiessling
Leading the Institute of Experimental
Molecular Imaging, Helmholtz Institute for Biomedical Engineering,
RWTH-University in Aachen
Since 2008 Professor Dr. Fabian Kiessling is leading the Institute of Experimental Molecular Imaging at the Helmholtz Institute for Biomedical Engineering at the RWTH-University in Aachen. Aim of his research is the development of novel diagnostic, theranostic and therapeutic probes as well of advanced imaging technologies and image analysis tools. In this context, a main focus of his research is the investigation and diagnostic assessment of vascular and microenvironmental tissue properties and the exploration of its impact on disease progression and therapy response.
Fabian Kiessling studied Medicine and did his thesis at the University in Heidelberg. Until the end of 2002, he worked as resident in the Department of Radiology at the German Cancer Research Center (DKFZ) in Heidelberg. In 2003 he changed to the Department of Medical Physics in Radiology of the DKFZ as leader of the Molecular Imaging group. In parallel, he did his clinical training at different Departments of the University of Heidelberg and received the board certification as Radiologist in 2007. Fabian Kiessling did his habilitation in experimental radiology in 2006. In 2008 he founded the invivoContrast GmbH together with Matthias Braeutigam.
Fabian Kiessling is author of more than 400 scientific publications and book chapters, edited four books and received many research awards, among those the „Emil Salzer Price for Cancer Research” and the “Richtzenhain Price”. Furthermore, he was awarded as Fellow of the World Molecular Imaging Society in 2019 and in 2019 and 2020 identified as “Highly Cited Researcher” by Clarivate Analytics (Web of Science).
He is founding member of the European Society for Functional and Molecular Imaging in Radiology (ESMOFIR), served as treasurer and secretary of the European Society for Molecular Imaging (ESMI), is founding member of the ESMI working group “Image Guided Therapy and Drug Delivery (IGTDD)“, and was chairman of the “Molecular Imaging” subcommittee of the European Society for Radiology (ESR). In addition, he is member of the Board of Trusties of the World Molecular Imaging Society and was program chair of the World Molecular Imaging Conference (WMIS) in New York in 2016.
Prof. Phillip Kuo
Professor
of Medical Imaging, Medicine and Biomedical Engineering, the University of
Arizona
Phillip Kuo graduated in chemistry from Harvard and then earned an MD/PhD from the University of Virginia. Post-graduate training included residency in Internal Medicine at UCLA and fellowship in Nuclear Medicine and residency in Radiology at Yale. He is Professor of Medical Imaging, Medicine and Biomedical Engineering at the University of Arizona. Scientific interests span basic, translational and clinical research in molecular imaging. As first or senior author, he has greater than 60 peer-reviewed publications. He has served as principal investigator/co-PI on multiple NIH grants and investigator-initiated trials. Experience includes design and supervision of phase I, 2 and 3 clinical trials.
Prof. Michael van Dam
R. Michael van Dam, Ph.D. is a Professor and Vice chair in the Department of Molecular & Medical Pharmacology at the University of California, Los Angeles, and an Associate Director of the Crump Institute for Molecular Imaging.
Prof. Michael van Dam's research focuses on developing novel technologies to increase access to radiopharmaceuticals (e.g., PET imaging tracers and theranostic agents), including microscale approaches for multi-step radiosynthesis, high-throughput methods for radiopharmaceutical development, and high-sensitivity techniques for radiochemical analysis. He has published over 70 papers and book chapters, and has been granted over 20 patents, related to these discoveries. Dr. van Dam is also a co-founder of Sofie, Inc., which has commercialized the ELIXYS FLEX/CHEM and PURE/FORM radiosynthesis platform based on technology and control software developed in his laboratory. He received his B.Sc. in Engineering Physics from Queen's University (Kingston, ON, Canada), M.A.Sc. in Computer Engineering from the University of Toronto (Toronto, ON, Canada), and Ph.D. in Applied Physics from the California Institute of Technology (Pasadena, CA, USA).
Stay Connected.
Join your fellow Nuclear Medicine peers in ANZSNM social media channels
Conference Manager
For all conference enquires, please talk to the team at: Event Studio Group Pty Ltd 60 Wellington Square, North Adelaide SA 5006 +61 8 8379 8222 ANZSNM2021@eventstudio.com.au
Privacy
To view the privacy statement, click here